89bio, Inc. Files 8-K Report
| Field | Detail |
|---|---|
| Company | 89bio, Inc. |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-k
Related Tickers: BIO
TL;DR
89bio filed a routine 8-K, confirming address and corporate details.
AI Summary
On May 1, 2025, 89bio, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 655 Montgomery Street, Suite 1500, San Francisco, CA 94111. The report does not contain specific financial results or operational updates beyond confirming the filing date and company information.
Why It Matters
This filing confirms 89bio, Inc.'s official reporting status and provides basic corporate information, which is standard for public companies.
Risk Assessment
Risk Level: low — This is a standard corporate filing with no new material financial or operational information disclosed.
Key Players & Entities
- 89bio, Inc. (company) — Registrant
- May 1, 2025 (date) — Date of earliest event reported
- 655 Montgomery Street, Suite 1500, San Francisco, CA 94111 (location) — Address of principal executive offices
- Delaware (jurisdiction) — State of incorporation
- 001-39122 (identifier) — Commission File Number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 1, 2025.
What is the principal executive office address for 89bio, Inc.?
The address of the principal executive offices is 655 Montgomery Street, Suite 1500, San Francisco, CA 94111.
In which state was 89bio, Inc. incorporated?
89bio, Inc. was incorporated in Delaware.
What is the Commission File Number for 89bio, Inc.?
The Commission File Number for 89bio, Inc. is 001-39122.
What is the SIC code for 89bio, Inc.?
The Standard Industrial Classification (SIC) code for 89bio, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding 89bio, Inc..